Eli Lilly and Company
Disubstituted pyrazole compounds

Last updated:

Abstract:

The present invention provides a compound of Formula I ##STR00001## or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating metabolic conditions, such as type 2 diabetes mellitus, heart failure, diabetic kidney disease, and non-alcoholic steatohepatitis.

Status:
Grant
Type:

Utility

Filling date:

16 Jun 2020

Issue date:

21 Sep 2021